Related references
Note: Only part of the references are listed.Pharmacokinetics of Ceftaroline in Normal Body Weight and Obese (Classes I, II, and III) Healthy Adult Subjects
Julie Ann Justo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience
Benjamin A. Lipsky et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
Trends in the Epidemiology of Osteomyelitis A Population-Based Study, 1969 to 2009
Hilal Maradit Kremers et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2015)
A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline
Felix K. Yam et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2014)
Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy
Anthony M. Casapao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline
Rupali Jain et al.
PHARMACOTHERAPY (2014)
Ceftaroline - a cause for neutropenia
R. H. Rimawi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2013)
Systemic Antibiotic Therapy for Chronic Osteomyelitis in Adults
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2012)
Affinity of Ceftaroline and Other β-Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae
K. Kosowska-Shick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection
G. Ralph Corey et al.
CLINICAL INFECTIOUS DISEASES (2010)
Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled-Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community-Acquired Pneumonia
Thomas M. File et al.
CLINICAL INFECTIOUS DISEASES (2010)
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
Mark H. Wilcox et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
G. Ralph Corey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States
Yigong Ge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate
BA Lipsky et al.
CLINICAL INFECTIOUS DISEASES (2004)
Risk factors and treatment outcomes in osteomyelitis
AD Tice et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?
J Ciampolini et al.
POSTGRADUATE MEDICAL JOURNAL (2000)
Share Paper
